Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity
about
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's diseaseNitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activationSpecific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapyTamoxifen induces apoptosis through cancerous inhibitor of protein phosphatase 2A-dependent phospho-Akt inactivation in estrogen receptor-negative human breast cancer cellsTargeting SET/I(2)PP2A oncoprotein functions as a multi-pathway strategy for cancer therapyCardamonin Suppresses TGF-β1-Induced Epithelial Mesenchymal Transition via Restoring Protein Phosphatase 2A ExpressionNitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells.PP2A-Mediated Anticancer Therapy.miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cellsNew sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors.tert-Butylhydroquinone mobilizes intracellular-bound zinc to stabilize Nrf2 through inhibiting phosphatase activity.Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer.Identification of potential pathways involved in the induction of cell cycle arrest and apoptosis by a new 4-arylidene curcumin analogue T63 in lung cancer cells: a comparative proteomic analysis.
P2860
Q24627125-921FCEA7-FA3D-4DF1-9C36-B01922972B48Q28483470-A8700006-896F-4E45-BF40-7548C7F211CBQ34700019-D2C8B1AE-93B6-4230-8DDE-8CDB36A4D503Q35000235-458D9161-7AAA-40CF-A383-4DC11DA01A1AQ35022139-FD1D7CC7-C759-40FA-8D63-36356E26B469Q35161277-F7C7119E-6A6B-4F08-B911-FE686E84EA06Q36050039-B5B61895-3B14-4B50-9D81-676BA9C9FD64Q36962531-8051B0AB-6584-45BB-A4F6-92D44AD40F12Q38168831-4F00F757-6593-47EB-B7CE-47EC669AF488Q38554814-21B67997-6464-4914-826E-4E8D9FF19547Q38696518-B09D2055-474D-422C-9F4A-A8E2021C9A12Q38872787-0600129D-FCFC-4E51-B773-D1E4DAAA3000Q38904928-A3578A6C-0597-4AA5-BA82-EA3A398FCDB9Q38971200-76459C21-DAAE-45F3-9AE9-947C1EBE1315Q39013461-B154729E-F481-4D6A-BDF6-9238F74FA44C
P2860
Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Dithiolethione compounds inhib ...... ls by increasing PP2A activity
@ast
Dithiolethione compounds inhib ...... ls by increasing PP2A activity
@en
type
label
Dithiolethione compounds inhib ...... ls by increasing PP2A activity
@ast
Dithiolethione compounds inhib ...... ls by increasing PP2A activity
@en
prefLabel
Dithiolethione compounds inhib ...... ls by increasing PP2A activity
@ast
Dithiolethione compounds inhib ...... ls by increasing PP2A activity
@en
P2093
P2860
P50
P356
P1433
P1476
Dithiolethione compounds inhib ...... ls by increasing PP2A activity
@en
P2093
C H Switzer
L A Ridnour
P Del Soldato
P2860
P2888
P304
P356
10.1038/ONC.2009.244
P407
P577
2009-08-24T00:00:00Z